Search results
Results from the WOW.Com Content Network
Aventis Pasteur, the vaccine division of the Sanofi-Aventis Group, changes its name to Sanofi Pasteur. 2008: Sanofi Pasteur acquires Acambis plc, a biotech company. 2009: Sanofi Pasteur acquires major stake in Hyderabad-based Shantha Biotechnics. [21] 2020: Sanofi Pasteur and GlaxoSmithKline have said they are starting clinical trials of their ...
Two class action lawsuits have been filed charging Sanofi Pasteur Inc. with violating U.S. antitrust laws, as a result of its bundling practices. [10] [11] The suits challenge Sanofi's alleged “anticompetitive scheme” [12] to maintain its monopoly in the U.S. meningitis vaccine market. [13] [14] These lawsuits have since been consolidated. [15]
The Sanofi–GSK COVID-19 vaccine, sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. [ 4 ] [ 5 ] The Sanofi–GSK COVID‑19 vaccine was approved for medical use in the European Union in November 2022.
Vaxigrip and its quadrivalent formulation Vaxigrip Tetra are split virus inactivated vaccines made by Sanofi Pasteur in Europe. [2] [26] Vaxigrip provides immune responses to three influenza strains and VaxigripTetra adds another B strain. VaxigripTetra was approved in Europe in 2016 except for infants younger than three years old. [2]
The vaccine development branch of the institute was separated early on and is now part of Sanofi Pasteur. [ 1 ] , [ 2 ] , [ 3 ] The current name was changed in 2009 from Mérieux Alliance. [ 1 ] The holding is owned through the Mérieux Alliance company at 68% by Alain and Alexandre Mérieux and at 32% by the Christophe and Rodolphe Mérieux ...
ACAM2000 is a vaccine developed by Acambis, which was acquired by Sanofi Pasteur in 2008, before selling the smallpox vaccine to Emergent Biosolutions in 2017. Six strains of vaccinia were isolated from 3,000 doses of Dryvax and found to exhibit significant variation in virulence.
The book surveys the history of vaccine development in the United States from 1887 to 1987 through the eyes of the people who worked at what is now Sanofi Pasteur, [4] the biologics division of Sanofi Aventis. [5] The Spirit of Swiftwater was Widmer's first book.
A branded formulation was marketed in the US as TriHIBit by Sanofi Pasteur, and administered by using the Sanofi DTaP vaccine Tripedia to reconstitute the Sanofi Hib vaccine ActHIB. [2] [3] [4] TriHIBit and Tripedia were discontinued in 2011. [5]